Empowered Funds LLC increased its holdings in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 141.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 153,834 shares of the company's stock after acquiring an additional 90,091 shares during the quarter. Empowered Funds LLC owned about 0.33% of Avanos Medical worth $2,449,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Quarry LP bought a new stake in Avanos Medical in the 3rd quarter valued at $42,000. KBC Group NV boosted its stake in Avanos Medical by 63.0% in the 3rd quarter. KBC Group NV now owns 2,833 shares of the company's stock valued at $68,000 after purchasing an additional 1,095 shares during the period. Intech Investment Management LLC bought a new stake in Avanos Medical in the 3rd quarter valued at $207,000. Atom Investors LP bought a new stake in Avanos Medical in the 3rd quarter valued at $210,000. Finally, EP Wealth Advisors LLC bought a new stake in Avanos Medical in the 3rd quarter valued at $212,000. 95.17% of the stock is owned by institutional investors and hedge funds.
Avanos Medical Price Performance
Shares of AVNS stock traded down $0.96 on Tuesday, hitting $15.61. 120,182 shares of the company's stock were exchanged, compared to its average volume of 543,658. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46. Avanos Medical, Inc. has a 12 month low of $14.98 and a 12 month high of $25.36. The stock has a market cap of $717.48 million, a P/E ratio of 45.91 and a beta of 0.98. The company has a 50 day moving average of $16.45 and a 200 day moving average of $20.05.
Analysts Set New Price Targets
Separately, StockNews.com downgraded Avanos Medical from a "strong-buy" rating to a "buy" rating in a research note on Sunday, November 3rd.
Read Our Latest Report on AVNS
About Avanos Medical
(
Free Report)
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Read More
Before you consider Avanos Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avanos Medical wasn't on the list.
While Avanos Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
